Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
08/14/2008 | WO2007072153A8 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
08/14/2008 | WO2007065288A8 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
08/14/2008 | US20080194837 Potassium Channel Opener Having Benzofuroindole Skeleton |
08/14/2008 | US20080194814 Process for making titanyl phthalocyanine |
08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
08/14/2008 | US20080194591 Anhydrous Crystalline Forms Of N-[1-(2-Ethoxyethyl)-5-(N-Ethyl-N-Methylamino)-7-(4-Methylpyridin-2-Yl-Amino)-1H-Pyrazolo[4,3-D]Pyrimidine-3-Carbonyl]Methanesulfonamide |
08/14/2008 | US20080194589 Pyrazolo[1,5-Alpha]Pyrimidinyl Derivatives Useful as Corticotropin-Releasing Factor (Crf) Receptor Antagonists |
08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
08/14/2008 | US20080194573 3-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns Diseases |
08/14/2008 | US20080194571 Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists |
08/14/2008 | US20080194557 methods of treating, managing and preventing pain, inflammation, cancer, and ocular diseases and disorders, and to compounds and pharmaceutical compositions useful in such methods |
08/14/2008 | US20080194529 Deuterated 3-(1-Methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin- -5-yl)-N-[2-(1-methyl-pyrrolidin-2-yl)-ethyl]-4-propoxy-benzenesulfonamide; combined with a second active agent; erectile dysfunction; hypotensive agents |
08/14/2008 | US20080190855 removing toxic heavy metal ions from water for drinking water filtration or environmental cleanup; carbon attached directly to the amino acid via carboxyl groups on the surface; converting surface carboxyl groups to acyl halide groups and then contacting with amino acid; carbon electrode; graphite powder |
08/14/2008 | CA2677365A1 2-amino-5, 7-dihydro-6h-pyrrolo [3, 4-d] pyrimidine derivatives as hsp- 90 inhibitors for treating cancer |
08/14/2008 | CA2677263A1 Compounds and compositions as modulators of gpr119 activity |
08/13/2008 | EP1956022A1 Compound for organic electroluminescent element and organic electroluminescent element |
08/13/2008 | EP1956021A1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
08/13/2008 | EP1956009A1 Aromatic compound |
08/13/2008 | EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands |
08/13/2008 | EP1954699A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
08/13/2008 | EP1954698A1 Spirocyclic compounds as hdac inhibitors |
08/13/2008 | EP1954673A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
08/13/2008 | EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis |
08/13/2008 | EP1664023B1 Sustituted isoquinoline derivatives and methods of use |
08/13/2008 | EP1585749B1 Diazepinoindole derivatives as kinase inhibitors |
08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
08/13/2008 | EP1537867B1 Method of photodynamic diagnosis for vascular diseases |
08/13/2008 | EP1461042B1 Use of desoxypeganine for treating clinical depression |
08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
08/13/2008 | EP1389098B1 Delivery of antipsychotics through an inhalation route |
08/13/2008 | EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
08/13/2008 | CN101243090A P38 MAP kinase inhibitors and methods for using the same |
08/13/2008 | CN101243089A Halogenated pyrazolo [1,5-A]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates |
08/13/2008 | CN101243088A P38 MAP kinase inhibitors and methods for using the same |
08/13/2008 | CN101243054A Synergistic composition amd method for inhibiting growth of microorganisms |
08/13/2008 | CN101243050A Pyrazolone derivatives |
08/13/2008 | CN101242839A Azaindazole compounds and methods of use |
08/13/2008 | CN101242832A Fused pyrazole as p38 MAP kinase inhibitors |
08/13/2008 | CN101239981A Pyrazolo and imidazo-pyrimidine derivatives |
08/13/2008 | CN101239943A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same |
08/13/2008 | CN101239942A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same |
08/13/2008 | CN101239935A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same |
08/13/2008 | CN100410296C Silica gel bonded with cucurbiturils |
08/13/2008 | CA2619136A1 Process for making titanyl phthalocyanine |
08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
08/12/2008 | US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy |
08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
08/12/2008 | US7410967 For combating phytopathogenic diseases on plants and harvested food crops; pyrido(2,3-B)pyrazine derivatives; volatile enough to be active in the vapour phase |
08/12/2008 | US7410933 Substituted thiene-3-ylsulphonylamino(thio)carbonyl-triazolin(thi)ones |
08/12/2008 | CA2420461C Preparations for oral administration |
08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
08/07/2008 | WO2008094602A2 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases |
08/07/2008 | WO2008094575A2 1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases |
08/07/2008 | WO2008094222A2 Porphyrin catalysts and methods of use thereof |
08/07/2008 | WO2008093639A1 Pyrazole compound |
08/07/2008 | WO2008092924A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol |
08/07/2008 | WO2008092831A1 Pteridinone derivatives as pi3-kinases inhibitors |
08/07/2008 | WO2008068600A3 An improved process for the preparation of zaleplo |
08/07/2008 | WO2008053301A3 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
08/07/2008 | WO2007091947A8 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
08/07/2008 | US20080188518 5-Substituted Imidazoles |
08/07/2008 | US20080188516 Imiadazo[4,5-c] pyridine compound and method of antiviral treatment |
08/07/2008 | US20080188496 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
08/07/2008 | US20080188494 fungicide; controlling phytopathogenic harmful fungi or the materials, plants, soil or seed to be protected against fungal attack; by reacting substituted beta -ketoesters with a 3-aminoazole to give 7-hydroxytriazolopyrimidines |
08/07/2008 | US20080188493 6-hex-5-enyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-ylamine; phytopathogenic fungi |
08/07/2008 | US20080188492 Organic Compounds |
08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
08/07/2008 | US20080188483 Compounds and Compositions as Protein Kinase Inhibitors |
08/07/2008 | US20080188482 [1H-Pyrazolo[3, 4-D]Pyrimidin-4-Yl]-Piperidine or -Piperazine Compounds as Serine-Theoronine Kinase Modulators (P70s6k, Atk1 and Atk2) for the Treatment of Immunological, Inflammatory and Proliferative Diseases |
08/07/2008 | US20080188478 Compounds Useful In Therapy |
08/07/2008 | US20080188471 Dipeptidyl Peptidase-IV Inhibiting Compounds, Method Of Preparing The Same, And Pharmaceutical Compositions Containing The Same As An Active Agent |
08/07/2008 | US20080188452 Macrocyclic Benzofused Pyrimidine Derivatives |
08/07/2008 | US20080188371 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat) |
08/07/2008 | CA2677168A1 Pteridinone derivatives as pi3-kinases inhibitors |
08/07/2008 | CA2677096A1 Kinase inhibitors |
08/07/2008 | CA2676665A1 Modulators of mitotic kinases |
08/07/2008 | CA2676658A1 Modulators of mitotic kinases |
08/06/2008 | EP1953163A1 Pteridinone derivatives as PI3-kinases inhibitors |
08/06/2008 | EP1953161A1 New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them |
08/06/2008 | EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
08/06/2008 | EP1953158A1 Bicyclic cinnamide compound |
08/06/2008 | EP1953148A1 Heterocyclic amide compound and use thereof |
08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
08/06/2008 | EP1951731A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
08/06/2008 | EP1951724A2 FUSED BICYCLIC mTOR INHIBITORS |
08/06/2008 | EP1951723A1 The application using non-covalent bond between a cucurbituril derivative and a ligand |
08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
08/06/2008 | EP1951691A1 Process for the preparation of n-triazinylammonium salts |
08/06/2008 | EP1951251A2 Spirohydantoin aryl cgrp receptor antagonists |
08/06/2008 | EP1951228A2 Bicyclic spirohydantoin cgrp receptor antagonists |
08/06/2008 | EP1749009B1 Method for producing a solution of pure triethylenediamine (teda) |
08/06/2008 | EP1476507B1 Compounds, compositions and uses |
08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |